Flash Sell! Exit This Cannabis Success Story For a Gain
The marijuana market may be red hot, but that doesn’t mean cannabis biopharma companies are held to a different standard. Just as with other biotech companies, they need to prove their therapies work in order to get the FDA’s stamp of approval. Whether the problem is commercialization, marketing or simply approval – we are up and share price is down. Time to collect our gains and move on…
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Profit Alert
The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.